Aesthetic Medicine Symposium - September 18-21 in Scottsdale, AZ!Secure Your Spot
Celebrating 20 Years of Excellence in Botox®, Aesthetic Medicine & Medical Weight Management Training & Certification
Aesthetic Medicine Symposium — Sept 18–21, Scottsdale, AZ Secure Your Spot →
IAPAM Learning Library
Long-Term Effects of Botox® Injections
A complete guide to how Botox® works, what treatment may involve, where it is used, and why qualified, patient-specific care shapes better decisions.
Participant practicing hands-on Botox® injection training at the IAPAM Aesthetic Medicine Symposium.
Background & effects
From Botulinum Toxin to Modern Clinical Use
Botox® is derived from a purified form of botulinum toxin, a substance historically associated with serious neurologic illness. Research into its ability to affect nerve-to-muscle signaling led to carefully controlled medical use.
Today, botulinum toxin products are used in both aesthetic and medical settings. In cosmetic treatment, the goal is commonly to soften the appearance of certain muscle-driven lines. In medical care, the same underlying mechanism is used for specific, product-labeled conditions that require their own clinical assessment and treatment plan.
The key point is not that Botox® is a one-size-fits-all solution. Its effect depends on the product, indication, treatment area, patient anatomy, dose, technique, and the clinician’s evaluation.
What patients should know
Results Are Temporary. Expectations Should Be Specific.
Botox® can soften the appearance of certain muscle-driven lines, but it is not designed to address every visible sign of aging. A thoughtful consultation focuses on dynamic lines, treatment goals, realistic outcomes, and follow-up.
01
Dynamic versus static concerns
Botox® Cosmetic is used for specified concerns involving muscle activity. A clinician can help distinguish these from lines related to skin quality, volume loss, or other factors.
02
Individual duration
Results vary. Treatment area, product, dose, technique, muscle activity, and individual response all affect how long a cosmetic effect may be visible.
03
Informed choices
Clear communication about expected effect, possible adverse reactions, and alternatives gives patients the context needed to decide whether treatment fits their goals.
Candidate considerations
Individual Assessment Comes First
Suitability is not determined by a single age range or a cosmetic concern alone. A qualified clinician should consider medical history, current health, medications, the proposed treatment area, expectations, and the product’s labeled indication before recommending treatment.
The current product label lists known hypersensitivity to a botulinum toxin preparation and infection at the proposed injection site as contraindications. Other health factors may affect whether treatment is appropriate, including conditions that influence neuromuscular function or breathing and swallowing risk.
Patients who are pregnant, breastfeeding, or managing other health conditions should discuss their individual situation with the treating clinician rather than rely on general online guidance.
What treatment may involve
What Happens During Botox® Treatment?
Botulinum toxin treatment consists of small, targeted injections that are typically performed in an office setting. The treatment plan is individualized: it should reflect the product being used, the labeled indication, the treatment area, the patient’s anatomy, and the desired result.
A qualified clinician starts by reviewing the patient’s goals, medical history, medications, prior treatment experience, and facial or functional movement. That assessment helps determine whether treatment is appropriate and, if it is, which muscles and injection pattern fit the individual case.
For aesthetic treatment, a fine needle is used to place the product in selected muscles. The clinician’s product knowledge, understanding of anatomy, dose selection, and technique all matter. Patients should receive individualized preparation and aftercare instructions; they should not stop or change prescribed medicines based on general online advice.
01
Assess
The clinician reviews anatomy, muscle activity, medical context, and the patient’s goals.
02
Plan
The product, indication, dose, and injection pattern are selected for the individual case.
03
Treat
The product is administered by targeted injection using a technique suited to the treatment area.
04
Follow up
The patient receives individualized instructions and knows when to contact the clinical team.
How the treatment effect develops
OnabotulinumtoxinA is an acetylcholine-release inhibitor and neuromuscular blocking agent. In practical terms, it reduces signaling to the targeted muscle, which can reduce the muscle activity associated with a selected concern. This is why treatment planning must be precise: the goal is to address the intended muscle activity while respecting the surrounding anatomy and the patient’s desired degree of movement.
For complete product information, including indication-specific dosing, contraindications, warnings, precautions, and adverse reactions, review the current BOTOX® Cosmetic prescribing information.
Product context
Botox® vs. Botox® Cosmetic: What Is the Difference?
BOTOX® and BOTOX® Cosmetic both contain onabotulinumtoxinA, but they are separate products with different FDA-approved indications and product labeling. BOTOX® Cosmetic is labeled for specified aesthetic indications in adults; BOTOX® is labeled for a range of medical indications.
The product, indication, patient assessment, dose, injection plan, and counseling must fit the treatment being considered. Potency units for BOTOX® and BOTOX® Cosmetic are specific to their preparation and are not interchangeable with other botulinum toxin products.
Topic
BOTOX® Cosmetic
BOTOX®
Active ingredient
OnabotulinumtoxinA
OnabotulinumtoxinA
FDA-labeled focus
Temporary improvement in the appearance of moderate-to-severe glabellar lines in adults
Temporary improvement in the appearance of moderate-to-severe lateral canthal lines in adults
Temporary improvement in the appearance of moderate-to-severe forehead lines in adults
Temporary improvement in the appearance of moderate-to-severe platysma bands in adults
Overactive bladder in eligible adult patients
Urinary incontinence due to detrusor overactivity associated with a neurologic condition in eligible adult patients
Neurogenic detrusor overactivity in eligible pediatric patients age 5 and older
Prophylaxis of headaches in adults with chronic migraine
Spasticity in patients age 2 and older
Cervical dystonia in adults
Severe primary axillary hyperhidrosis in eligible adults
Blepharospasm associated with dystonia in patients age 12 and older
Strabismus in patients age 12 and older
Important limits
Use is limited to its labeled aesthetic indications and adult population. The treating clinician determines whether the individual patient and treatment area are appropriate.
Not every medical use of botulinum toxin is FDA-labeled. The BOTOX® label does not establish safety and effectiveness for episodic migraine or hyperhidrosis in body areas other than the axillae.
Clinical takeaway
Shared active ingredient does not mean identical use. The product label, patient assessment, relevant anatomy, dose, administration plan, and follow-up requirements should match the specific indication being treated.
BOTOX® Cosmetic
Active ingredient
OnabotulinumtoxinA
FDA-labeled aesthetic indications in adults
Moderate-to-severe glabellar lines
Moderate-to-severe lateral canthal lines
Moderate-to-severe forehead lines
Moderate-to-severe platysma bands
Important context
The treatment is intended for the temporary improvement in appearance of specified muscle-activity-related concerns. A clinician determines whether the patient and treatment area are appropriate.
BOTOX®
Active ingredient
OnabotulinumtoxinA
FDA-labeled medical indications
Overactive bladder in eligible adult patients
Urinary incontinence due to detrusor overactivity associated with a neurologic condition in eligible adult patients
Neurogenic detrusor overactivity in eligible pediatric patients age 5 and older
Prophylaxis of headaches in adults with chronic migraine
Spasticity in patients age 2 and older
Cervical dystonia in adults
Severe primary axillary hyperhidrosis in eligible adults
Blepharospasm associated with dystonia in patients age 12 and older
Strabismus in patients age 12 and older
Important limits
The BOTOX® label does not establish safety and effectiveness for episodic migraine or hyperhidrosis in body areas other than the axillae.
Facial expressions rely on repeated muscle movement. Over time, that movement can contribute to dynamic lines in selected areas of the face. BOTOX® Cosmetic is used for specified, muscle-activity-related aesthetic concerns in adults; a qualified clinician assesses facial anatomy, movement patterns, patient goals, and the appropriate product-label context before treatment.
For clinicians who plan to add aesthetics to their practice, facial treatment requires more than knowing popular treatment areas. It requires a working understanding of facial anatomy, assessment, product selection, technique, patient communication, and follow-up. New injectors should complete a comprehensive CME-approved training program; experienced injectors should continue developing their Botox® injection techniques.
A treatment plan should not begin with a fixed number of units or a universal injection map. It begins with how the individual patient moves, which muscles contribute to the concern, the relationship between the forehead and brow, the desired degree of movement, and the risks that need to be discussed before treatment.
Forehead lines
Forehead lines are often associated with frontalis muscle activity. Assessment should account for the brow, the pattern of expression, and the balance of surrounding muscles. Some patients want a very smooth appearance; others prefer to retain more expressive movement.
Glabellar lines
The “11s” between the brows are commonly associated with corrugator and procerus muscle activity. These lines may be influenced by anatomy, expression, and genetics. See IAPAM’s BOTOX® education resource for related training context.
Lateral canthal lines
Crow’s feet are associated with orbicularis oculi activity around the outer eye. The desired result, eye-area anatomy, degree of movement, and individualized risk assessment all matter when treatment is considered.
What Botox® Cosmetic does—and does not—address
Botulinum toxin products are designed to address selected muscle-driven concerns. Lines related primarily to sun damage, skin texture, volume loss, or structural change may not respond in the same way. Deep lines around the mouth or nose may require a different clinical conversation and, in some cases, another treatment approach.
This educational overview does not replace patient-specific medical advice or the current BOTOX® Cosmetic prescribing information.
Beyond aesthetic medicine
How Botox® Works in Other Areas of the Body
Botulinum toxin products are often associated with aesthetic medicine, but BOTOX® also has FDA-labeled medical uses. These uses are not interchangeable with cosmetic treatment. Each requires indication-specific evaluation, treatment planning, administration, patient counseling, and follow-up.
The same broad mechanism—reducing signaling to selected muscles or other targeted structures—can be used differently depending on the condition being treated. The clinical objective, dose, injection sites, expected outcome, and potential adverse reactions vary by indication.
Patients and clinicians should avoid treating “Botox®” as a single, generic intervention. The correct product, current product label, clinical specialty, and patient-specific assessment matter in both aesthetic and medical care.
Severe underarm sweating
BOTOX® is indicated for severe primary axillary hyperhidrosis in eligible adults when topical agents are not enough. The label does not establish safety and effectiveness for hyperhidrosis in body areas other than the axillae, so treatment should follow indication-specific assessment and guidance.
Chronic migraine
BOTOX® is indicated for prophylaxis of headaches in adults with chronic migraine, defined in the label as 15 or more headache days per month lasting four hours or longer. It is not labeled as a cure for migraine and is not established for episodic migraine.
Spasticity and cervical dystonia
BOTOX® is indicated for spasticity in patients age 2 and older and for cervical dystonia in adults. These applications require a distinct examination, muscle selection process, dose plan, and monitoring approach from cosmetic treatment.
Eye and bladder conditions
The BOTOX® label also includes selected bladder conditions, blepharospasm associated with dystonia, and strabismus. These medical uses are managed within the relevant clinical specialty and product-specific guidance.
How to explain medical use clearly
Patients may associate botulinum toxin only with facial aesthetics. A clear explanation connects the condition to the treatment goal: in medical care, the aim may be to reduce selected symptoms or address a labeled condition—not to provide a universal cure or to use an aesthetic protocol for a medical problem.
For complete indication, limitations-of-use, dosing, contraindication, warning, and adverse-reaction information, consult the current BOTOX® prescribing information.
Long-term effects & safety
Long-Term Considerations and Potential Side Effects
Botox® treatment is temporary, but safety is not a one-time conversation. The patient’s response, treatment goals, medical context, and the appropriateness of future treatment should be assessed over time. A complete discussion distinguishes common or localized reactions from uncommon but potentially serious symptoms that need prompt attention.
The most appropriate safety information comes from the current product label and the treating clinician. For BOTOX® Cosmetic, adverse reactions vary by indication and may include eyelid ptosis, eyelid edema, headache, and brow ptosis. Injection-site reactions and other effects can also occur.
Repeated treatment does not mean the same plan should be repeated automatically. Anatomy, response, health history, and patient goals can change. Ongoing care should be guided by clinical evaluation and current labeling rather than assumptions about permanent effects or a guaranteed pattern of response.
Localized and eye-related effects
Effects near the treatment area can include injection-site concerns and, for treatment near the eye, symptoms such as eyelid drooping, eye irritation, dry eye, blurred vision, swelling, or tearing. New or concerning eye symptoms should be discussed promptly with the treating clinician.
Hypersensitivity reactions
Serious or immediate hypersensitivity reactions have been reported with botulinum toxin products. The current label describes reactions that may include anaphylaxis, urticaria, soft-tissue edema, and dyspnea. Urgent medical evaluation is needed when a serious allergic reaction is suspected.
Muscle effects and response changes
Botulinum toxin affects neuromuscular signaling in targeted areas. The desired effect, degree of movement reduction, and adverse-effect risk depend on the indication, individual anatomy, dose, technique, and product-specific guidance. New weakness or a concerning change in function should be assessed clinically.
Why indication matters
Medical and cosmetic uses have different labeled doses, treatment areas, risks, and monitoring needs. Higher-risk medical contexts should be managed within the appropriate specialty, not through an aesthetic-treatment framework.
Important safety information
The BOTOX® Cosmetic label carries a boxed warning about distant spread of toxin effect. Symptoms consistent with botulinum toxin effects have been reported hours to weeks after injection. The full prescribing information contains complete warnings, precautions, contraindications, adverse reactions, and product-specific safety information.
Additional safety resources
The official label should guide clinical safety decisions. These original article links are retained as additional background reading.
Good outcomes depend on clear expectations, patient-centered communication, and sound clinical technique. Patients need information they can understand about what a procedure is designed to do, what it cannot do, and what follow-up looks like.
For clinicians, continuing education supports the duty of care behind every treatment decision: assessment, product knowledge, facial and functional anatomy, communication, technique, and response planning. For patients, the right next step is a conversation with a qualified licensed clinician who can evaluate their individual situation.
For physicians and advanced practice clinicians
Build Knowledge Before You Inject
High-quality injector education connects patient assessment, facial anatomy, product knowledge, technique, communication, and response planning. It supports the clinical judgment needed to practice responsibly.
These answers reinforce the article’s central themes: treatment is temporary, suitability is individual, product labeling matters, and qualified care supports better decisions.
How long do Botox® results typically last?
Botox® effects are temporary. Cosmetic duration varies by treatment area, product, dose, technique, individual muscle activity, and patient-specific factors. The current BOTOX® Cosmetic label describes an approximately three-to-four-month duration for glabellar lines.
What happens as Botox® wears off?
As the effect fades, the targeted muscle gradually resumes its usual activity and movement. The cosmetic effect diminishes over time, which is expected. Future treatment decisions should follow the individual patient’s response, goals, and clinical guidance.
Does repeated Botox® treatment create permanent results?
No. Botox® treatment is temporary, and ongoing cosmetic results require future treatment decisions. Individual response can change over time, so patients should not assume that an effect will be permanent or follow the same pattern for everyone.
Who may not be a suitable candidate for Botox® treatment?
Suitability depends on a clinician’s review of medical history, current health, medications, and treatment goals. The current label lists known hypersensitivity to a botulinum toxin preparation and infection at the proposed injection site as contraindications. Other health factors may also affect whether treatment is appropriate.
What is the difference between Botox® and Botox® Cosmetic?
Both are associated with onabotulinumtoxinA, but their product labeling and FDA-approved indications differ. Botox® Cosmetic is associated with specified aesthetic indications in adults, while Botox® has separate medical indications.
Why does injector training matter for Botox® treatments?
Injector education supports patient assessment, anatomy knowledge, product-specific understanding, technique selection, and informed decision-making. A clinician’s duty of care includes appropriate evaluation, communication, and a treatment plan tailored to the individual patient.
Educational information only: This overview does not replace individual medical advice, diagnosis, or treatment. For full product information, consult the current BOTOX® Cosmetic prescribing information.
Free CME Training
Try IAPAM’s Online Botox® Training — Free
Get instant access to a complete Botox® training module and earn 1 AMA PRA Category 1 CME at no cost. Covers facial anatomy, crow’s feet injection technique, patient consultation, and safety protocols.
Starting an aesthetic practice can feel overwhelming — but it doesn’t have to be. These four essential pillars will guide you toward building a successful, independent, and sustainable aesthetic practice with confidence.
New to injecting Botox®? This guide walks you through the most common mistakes—and how to avoid them—so you can deliver safe, natural-looking results your patients will love.
Letybo® received FDA approval on February 29, 2024, for the temporary improvement of moderate to severe glabellar lines in adult patients. With its high purity, precise diffusion pattern, and impressive clinical results, Letybo® offers medical providers a valuable new option in aesthetic medicine.
